Project Details
Description
A Randomized, Double-blind, Placebo-controlled, Multi-center. Cross-over Study of Rosuvastatin in Children and Adolescents (aged 6 to <18 years) with Homozygous Familial Hypercholesterolemia (HoFH)
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/14 → 4/30/17 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.